Compass Therapeutics (CMPX) Interest & Investment Income (2019 - 2023)
Compass Therapeutics recorded quarterly Interest & Investment Income of $2.0 million in Q4 2023, up 0.82% quarter-over-quarter from $2.0 million in Q3 2023, and up 52.86% year-over-year from $1.3 million in Q4 2022.
Compass Therapeutics' Interest & Investment Income history runs 5 years deep, the most recent figure standing at $2.0 million for Q4 2023.
- In Q4 2023, Interest & Investment Income rose 52.86% year-over-year to $2.0 million; the TTM figure through Dec 2023 stood at $7.3 million (up 208.89% YoY), while the FY2023 annual figure was $7.9 million, up 233.43% from the prior year.
- Interest & Investment Income came in at $2.0 million for Q4 2023 at Compass Therapeutics, up from $2.0 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $2.1 million in Q2 2023 to a low of $1000.0 in Q3 2021.
- A 5-year average of $590866.7 and a median of $176000.0 in 2019 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income tumbled 97.05% in 2020 and jumped 62200.0% in 2022, its largest moves.
- Compass Therapeutics' Interest & Investment Income stood at $176000.0 in 2019, then slumped by 87.5% to $22000.0 in 2020, then sank by 81.82% to $4000.0 in 2021, then surged by 32250.0% to $1.3 million in 2022, then soared by 52.86% to $2.0 million in 2023.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $2.0 million, $2.0 million, and $2.1 million for Q4 2023, Q3 2023, and Q2 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Compass Therapeutics | 418.47 Mn | 223.78 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 1.98 Mn |
| Sep 30, 2023 | 1.96 Mn |
| Jun 30, 2023 | 2.06 Mn |
| Dec 31, 2022 | 1.29 Mn |
| Sep 30, 2022 | 623,000.00 |
| Jun 30, 2022 | 424,000.00 |
| Mar 31, 2022 | 20,000.00 |
| Dec 31, 2021 | 4,000.00 |
| Sep 30, 2021 | 1,000.00 |
| Mar 31, 2021 | 15,000.00 |
| Sep 30, 2020 | 22,000.00 |
| Jun 30, 2020 | 7,000.00 |
| Mar 31, 2020 | 41,000.00 |
| Sep 30, 2019 | 176,000.00 |
| Jun 30, 2019 | 237,000.00 |